Symptom exaggeration and symptom validity testing in persons with medically unexplained neurologic presentations
- PMID: 29443178
- PMCID: PMC5764424
- DOI: 10.1212/CPJ.0000000000000092
Symptom exaggeration and symptom validity testing in persons with medically unexplained neurologic presentations
Abstract
Neurologists often evaluate patients whose symptoms cannot be readily explained even after thorough clinical and diagnostic testing. Such medically unexplained symptoms are common, occurring at a rate of 10%-30% among several specialties. These patients are frequently diagnosed as having somatoform, functional, factitious, or conversion disorders. Features of these disorders may include symptom exaggeration and inadequate effort. Symptom validity tests (SVTs) used by psychologists when assessing the validity of symptoms and impairments are structured, validated, and objectively scored. They could detect poor effort, underperformance, and exaggeration. In settings with appropriate prior probabilities, detection rates for symptom exaggeration have diagnostic utility. SVTs may help in moderating expensive diagnostic testing and redirecting treatment plans. This article familiarizes practicing neurologists with their merits, shortcomings, utility, and applicability in practice.
Figures

Similar articles
-
Factitious disorders and malingering in relation to functional neurologic disorders.Handb Clin Neurol. 2016;139:509-520. doi: 10.1016/B978-0-12-801772-2.00042-4. Handb Clin Neurol. 2016. PMID: 27719868 Review.
-
Measures of Symptom Exaggeration for Mental Health Disorders: A Systematic Review.J Insur Med. 2015;45(2):103-9. doi: 10.17849/insm-45-02-103-109.1. J Insur Med. 2015. PMID: 27584846
-
Medical Evaluation Board Involvement, Non-Credible Cognitive Testing, and Emotional Response Bias in Concussed Service Members.Mil Med. 2018 Nov 1;183(11-12):e546-e554. doi: 10.1093/milmed/usy038. Mil Med. 2018. PMID: 29590406
-
Clinical utility of the Neurobehavioral Symptom Inventory validity scales to screen for symptom exaggeration following traumatic brain injury.J Clin Exp Neuropsychol. 2015;37(8):853-62. doi: 10.1080/13803395.2015.1064864. Epub 2015 Aug 6. J Clin Exp Neuropsychol. 2015. PMID: 26245293
-
Malingering and factitious disorder.Pract Neurol. 2019 Apr;19(2):96-105. doi: 10.1136/practneurol-2018-001950. Epub 2018 Nov 13. Pract Neurol. 2019. PMID: 30425128 Review.
Cited by
-
Salivary cortisol is associated with cognitive changes in patients with fibromyalgia.Sci Rep. 2021 Jan 14;11(1):1311. doi: 10.1038/s41598-020-79349-0. Sci Rep. 2021. PMID: 33446677 Free PMC article. Clinical Trial.
-
Why functional neurological disorder is not feigning or malingering.Nat Rev Neurol. 2023 Apr;19(4):246-256. doi: 10.1038/s41582-022-00765-z. Epub 2023 Feb 16. Nat Rev Neurol. 2023. PMID: 36797425 Review.
-
Examining the Clinical Utility of Selected Memory-Based Embedded Performance Validity Tests in Neuropsychological Assessment of Patients with Multiple Sclerosis.Neurol Int. 2021 Sep 23;13(4):477-486. doi: 10.3390/neurolint13040047. Neurol Int. 2021. PMID: 34698256 Free PMC article.
References
-
- Stone J, Carson A, Duncan R. Symptoms “unexplained by organic disease” in 1144 new neurology out-patients: how often does the diagnosis change at follow-up? Brain. 2009;132:2878–2888. - PubMed
-
- Mittenberg W, Patton C, Canyock EM, Condit DC. Base rates of malingering and symptom exaggeration. J Clin Exp Neuropsychol. 2002;24:1094–1102. - PubMed
-
- Rogers R. Clinical Assessment of Malingering and Deception. New York: The Guilford Press; 2012.
-
- Parees I, Saifee TA, Kassavetis P. Believing is perceiving: mismatch between self-report and actigraphy in psychogenic tremor. Brain. 2011;135:117–123. - PubMed
-
- Pareés I, Kassavetis P, Saifee TA. Failure of explicit movement control in patients with functional motor symptoms: explicit control and functional symptoms. Mov Disord. 2013;28:517–523. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources